Category: InVivo Therapeutics Corp.
Veran Medical Technologies appoints former Stryker CFO Curt Hartman as a member of its board of directors.
Veran Medical Technologies said it has brought in former Stryker (NYSE:SYK) CFO Curt Hartman to join its board of directors.
Shares of InVivo Therapeutics gain more than 50% by the end of the day Friday after the company announces that it's ready to set aside its hydrogel product development to focus on an upcoming clinical trial of its degradable spinal scaffold.
Sir John Buchanan, the chairman of Smith & Nephew, is reportedly getting ready to step down from the medical device company's board of directors.
Troubled InVivo Therapeutics gains back some lost ground on Wall Street on news that it's appointed a new interim CFO after the last one called it quits after only 2 weeks.
Medical device maker InVivo Therapeutics (OTC:NVIV) gained back some Wall Street points today after announcing the appointment of Gregory Perry as the company's new interim CFO, effective Monday, September 23.
Interim CFO Sean Moran quits InVivo Therapeutics after just 2 weeks on the job, sending share prices down nearly 22% today.
InVivo Therapeutics (OTC:NVIV) shares plunged some 22% today after the medical device company reported that its interim CFO, appointed 2 weeks ago after the sudden departure of CEO & CFO Frank Reynolds, had resigned effective immediately.
InVivo shares lose nearly half their value after the company announces a delay to its spinal treatment clinical trials.
InVivo Therapeutics chairman, CEO & CFO Francis Reynolds resigns suddenly due to a "medical condition," according to a company announcement.
InVivo Therapeutics (OTC:NVIV) is getting a top-line shuffle after chairman, CEO and CFO Francis Reynolds resigned suddenly due to a "medical condition."